Glacial Gold(TM) Vape Cartridges and Bottled Oils Available in B.C.
Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) ("Nextleaf", "OILS", or the "Company"), a federally regulated producer of cannabis oil that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids, is pleased to announce that the Company's wholly owned subsidiary has completed its first shipment of Glacial Gold™ CBD and THC products to the British Columbia Liquor and Distribution Branch, the sole wholesale distributor of non-medical cannabis in British Columbia. The debut product assortment under Nextleaf's award-winning prohibition-era consumer brand, Glacial Gold™, is now available at B.C. Cannabis Stores and private cannabis retailers across British Columbia.
"We're excited to launch in our B.C. backyard first, with a portfolio of large format vape and oil products, all broadly appealing and validated formulations, at accessible price points. We put the emphasis where it counts. Product quality and consumption experience matter most, not excessive packaging, or elaborate promotions," said Emma Andrews, Director of Marketing at Nextleaf. "We're confident that value is a driving factor behind the majority of product decisions, particularly in the vape and bottled oil categories".
To view an enhanced version of this graphic, please visit:
The initial vape lineup from Glacial Gold™ is offered in two potency levels to match a consumers tolerance level or consumption occasion. The Session THC Vape features a full potency THC profile for cannabis enthusiasts who seek a more elevated experience and connection. The Anytime 1:1 Vape is formulated with a balanced THC and CBD profile for consumers looking for a more moderate, go-to vape.
Both vapes will be initially available in flavour profiles inspired by natural aromas found throughout B.C. and terpenes found in cannabis. "We've intentionally formulated our custom blends without the use of excessive botanical terpenes allowing you to deeply enjoy every draw without being overpowering," said Andrews. "We've validated the desirability through extensive sensory studies with human participants under our Research Licence, which allowed us to develop an extended assortment of compelling flavour profiles to offer variety and adaptability to early customer and retailer feedback."
Flavours include Glacial Fresh Mint with refreshing alpine aromas found in the B.C. backcountry, and Berry Lemonade, reminiscent of fresh-picked berries from the Okanagan.
Glacial Gold™ Distilled CBD 50 Oil, Distilled THC 30 Oil, and Distilled 30/30 Blend feature high-purity distillate in a base of organic MCT (medium chain triglycerides) oil for a premium consumption experience, without premium pricing. A clean tasting, and neutral oil allowing for the greatest flexibility in use and consumption occasions.
"By leveraging our patented high-efficiency ingredient processing technology, the Glacial Gold™ brand is being positioned as a price-point and value leader in distillate focused product categories. Ensuring we honoured our roots in B.C. has been a personal mission as we expand into consumer products," said Paul Pedersen, Chief Executive Officer at Nextleaf.
Glacial Gold™ distillate is produced through the Company's patented, automated closed-loop, chilled-alcohol extraction plant at Nextleaf Labs Ltd., a Health Canada licensed processing facility. Nextleaf's proprietary technology efficiently transforms cannabis and hemp grown in BC and throughout Canada into high-purity cannabinoid-rich distillate at an industrial scale.
Nextleaf is a federally regulated producer of cannabis oil that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids. Nextleaf supplies cannabis oils to its wholesale customers and distributes consumer products under its award-winning prohibition-era brand, Glacial Gold™. Nextleaf's proprietary closed-loop automated extraction plant in Metro Vancouver has a design capacity to process 600 kilos of dried cannabis into oil per day. Nextleaf is developing delivery technology through its Health Canada Research Licence with sensory evaluation of cannabis via human testing. The Company owns 15 U.S. patents and has been issued over 80 patents globally.
For more information please contact:
Jason McBride, Corporate Development
604-283-2301 (ext. 219)
On behalf of the Board of Directors of the Company,
Paul Pedersen, CEO
Certain statements contained in this press release constitute "forward-looking statements". All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company's ability to capitalize on its IP portfolio,the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The CSE has not reviewed or approved the contents of this press release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/95982